Gamida Cell Ltd. vs Immix Biopharma (Nasdaq: IMMX)
Gamida Cell Ltd.
Working to turn cells into powerful therapeutics for patients with cancer
93 employees · est. 1998 · Boston, United States
-logo.jpg "Immix Biopharma (Nasdaq: IMMX)"){kind=logo}
Immix Biopharma (Nasdaq: IMMX)
Autoimmune CAR-T Clinical Trailblazer. CAR-T cell therapy for AL Amyloidosis and other autoimmune diseases
48 employees · est. 2012 · Los Angeles, United States
Gamida Cell Ltd. is the older company (1998 vs 2012); Gamida Cell Ltd. is the larger of the two.
Side-by-Side Comparison
| Metric | Gamida Cell Ltd. | Immix Biopharma (Nasdaq: IMMX) |
|---|---|---|
| Founded | ||
| Founded | 1998 older | 2012 |
| Headquarters | ||
| Headquarters | Boston, United States | Los Angeles, United States |
| Employees | ||
| Employees | 93 larger | 48 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Post-IPO Debt | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $292.51M | $15.00M |
| Funding Rounds | ||
| Funding Rounds | 13 | 2 |
| Services | ||
| Services | Not tracked yet | Development of CAR-T therapies, Clinical trials for AL Amyloidosis, Research in cell therapy technologies, Regulatory compliance and approvals |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with relapsed/refractory AL Amyloidosis, Biopharma investors, Healthcare institutions, Medical professionals |
| Taxonomy | ||
| Taxonomy | Cell TherapyBiopharmaceuticalNAM TechnologyCancer TreatmentStem Cell TransplantNK Cell Therapy +6 | ImmunotherapyCAR-T Cell TherapyAutoimmune DiseasesAL AmyloidosisBiopharmaceuticalCell Therapy +9 |
| Website | ||
| Website | gamida-cell.com | immixbio.com |
About Gamida Cell Ltd.
Gamida Cell Ltd. is a biotechnology and healthcare company based in the United States. The company's slogan, "Working to turn cells into powerful therapeutics for patients with cancer," reflects its mission to revolutionize cell therapy for cancer treatment. Founded in 1998, Gamida Cell is a pioneer...
About Immix Biopharma (Nasdaq: IMMX)
Immix Biopharma (Nasdaq: IMMX), a clinical-stage biopharmaceutical innovator, is pioneering the development of cell therapies targeting AL Amyloidosis and other autoimmune disorders. Their flagship product, the CAR-T cell therapy NXC-201, holds FDA IND clearance and is currently under evaluation in...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Gamida Cell Ltd. and Immix Biopharma (Nasdaq: IMMX) for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Gamida Cell Ltd. or Immix Biopharma (Nasdaq: IMMX) moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Gamida Cell Ltd. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Gamida Cell Ltd. on 12 Sep 2024, and Immix Biopharma (Nasdaq: IMMX) on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
